Search Results
Results found for "opioid signaling"
- Dr. John Streicher | Dr. GPCR Ecosystem
It turns out that it was signal transduction, and he worked on the signaling cascades involved in heart His encounter and interest in signaling in the context of GPCRs during his postdoctoral training in Dr Today, John and his team focus on understanding how signal transduction cascades downstream of the opioid receptors work, including the unique organization of chaperone protein Hsp90 modulation of opioid signaling
- Regulation and role of mitochondria delta opioid receptors
Committee Sponsors GPCR Retreat Program < Back to schedule Regulation and role of mitochondria delta opioid pharmacology and has published seminal papers where he used various approaches to describe the role of opioid pain and anagesia as well as to study the mechanisms involved in the cellular trafficking of the delta opioid
- Can we preserve opioid pain relief without the side effects? 🔬 On Ep.166 of the Dr.GPCR Podcast, Ben Clements shares how positive allosteric modulators (PAMs) at the mu-opioid receptor could revolutionize treatment —with a 10x boost in methadone efficacy. Tune in for a masterclass on translational pharmacology, curiosity-driven science, and meaningful mentorship. 🎧 Full episode: Ep 166 with Dr. Ben Clements #GPCRresearch #DrGPCR #GPCRpodcast #OpioidPharmacology #DrugDiscovery | Dr. GPCR Ecosystem
Home → Flash News → Can we preserve opioid pain relief without the side effects? GPCR Podcast Can we preserve opioid pain relief without the side effects? Due to Intellectual Property Gaps 👉 Why has intellectual property become a first-order fundraising signal intellectual property is no longer something that comes up late in the process. 👉 It has become an early signal to Avoid the Most Common Data Pitfalls Binding affinity appears straightforward: add ligand, measure signal
- Dr. Amynah Pradhan | Dr. GPCR Ecosystem
Paul Clarck , where she studied opioid receptors. She then returned to academia and worked on opioids as a postdoctoral trainee with Dr. Brigitte Kieffer , where she studied ligand-directed signaling at the delta-opioid receptor. Amynah studied how arrestins regulate ligand-directed signaling at delta-opioid receptors, and it is Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic
- Dr. Mark Connor | Dr. GPCR Ecosystem
Postdoc with Graeme Henderson (Bristol, opioids and Ca signaling) and Mac Christie (Sydney, opioids in Grant-funded independent research positions from 2001 at University of Sydney (opioids and sensory neurons visiting scientist with Ed McCleskey, sensory neuron properties); Pain Management Research Institute (more opioids Focus on study of drugs and toxins on GPCR (opioid, cannabinoid receptor) and ion channel (K, Ca, TRP
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
Catherine Demery shares how she found clarity and purpose in academic opioid research. Fentanyl and xylazine are pushing the opioid crisis into dangerous new territory, and Catherine Demery Her research combines cutting-edge GPCR signaling studies with real-time public health data from Michigan Why This Matters Fentanyl : Potent synthetic opioid that decreases inhalation rate. Why xylazine is an emerging overdose threat and how it differs mechanistically from opioids.
- Check out the new optical BRET-based biosensor, Gαi bONE-GO! In neuronal cell lines, the use of Gαi bONE-GO revealed that several natural opioid neuropeptides act as partial agonists, contrary to their previous characterization as full agonists. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! ➡️https://buff.ly/e6gAlBv #gpcr#drgpcr | Dr. GPCR Ecosystem
In neuronal cell lines, the use of Gαi bONE-GO revealed that several natural opioid neuropeptides act In neuronal cell lines, the use of Gαi bONE-GO revealed that several natural opioid neuropeptides act
- “Research is all about knowing when to walk and when to run.” –Ben Clements In Ep. 166 of the Dr.GPCR Podcast, hear how a postdoc is reshaping the conversation on opioid use, imposter syndrome, and the power of collaborative science. Why early-career voices are critical in GPCR drug discovery —and how lab culture makes all the difference. 🎧 Watch here: https://buff.ly/Kr3qKud #GPCRresearch #DrGPCR #GPCRpodcast #OpioidPharmacology #DrugDiscovery | Dr. GPCR Ecosystem
Ben Clements In Ep. 166 of the Dr.GPCR Podcast, hear how a postdoc is reshaping the conversation on opioid Ben Clements In Ep. 166 of the Dr.GPCR Podcast, hear how a postdoc is reshaping the conversation on opioid
- Dr. Graciela Pineyro | Dr. GPCR Ecosystem
Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling , trafficking, and their ability to activate different signaling pathways and signaling bias.
- Dopamine-Mediated Motor Recovery after Ischemic Stroke
the regulation of axonal transport by tricyclic antidepressants (M.Sc.) and molecular pharmacology of opioid The Tiberi Lab pursues the study of the molecular, structural, pharmacological and signaling features More specifically, we investigate the druggability potential of new signaling partners we identified
- Trainee Symposium I
My interests in research are primarily directed towards methods that study GPCRs and GPCR signaling, In my current research project I use iPSC-derived cardiac fibroblasts to examine cellular signaling in GPCR Title: Characterization of Novel Opioid-Neurotensin Bifunctional Ligands Designed to Target Pain protein-coupled receptors (GPCRs) ligands for the treatment of chronic pain but also in deciphering cellular signaling Synapse-Associated Protein 102 and Post-Synaptic Density 95 Differentially Shape Dopamine D1 Receptor Signaling
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
pain pathway What it means to “teach AI protein dynamics,” and how Superluminal is using it to predict signaling /PhD, a rejection letter pivoted him into a PhD program at the University of Iowa, where he studied opioid Driven by the opioid crisis and the lack of non-addictive pain treatments, Ajay co-founded Blue Therapeutics company using machine learning to explore GPCR structure-function relationships and predict biased signaling
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
GPCR scientist Ben Clements shares how positive allosteric modulators could transform opioid therapy GPCRs and the Opioid Crisis: A New Pharmacological Frontier Now at the University of Michigan, Ben focuses on positive allosteric modulators (PAMs) targeting opioid receptors. “We’re enhancing the powerful pain-relieving effects of opioids while limiting respiratory depression uses in vitro and in vivo models to discover and characterize novel treatments for chronic pain and opioid
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
These ligands stimulate receptor β-arrestin recruitment without activating canonical G protein signaling Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor signaling , they are exciting tools for linking distinct signaling pathways with their physiological effects and selectivity can be leveraged in the development of safe and effective treatments for stimulant and opioid
- Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem
He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and Thomas Sakmar’s laboratory at The Rockefeller University, where she study’s the signaling and degradation She is currently working to understand the signaling and degradation of GPCRs in disease states to help lab where she helped to investigate the role of various ATP-sensitive potassium channels in pain and opioid
- Dr. Graciela Pineyro | Dr. GPCR Ecosystem
She has done extensive work on the molecular pharmacology of opioid receptors and is currently focusing
- GPCR Retreat Schedule 2023
Coffee Break 3 Read More Friday, November 3rd / 10:40 AM Regulation and role of mitochondria delta opioid of Saskatchewan Read More Friday, November 3rd / 11:55 AM Unveiling Non-Canonical Functions for Gαq Signaling Friday, November 3rd / 1:30 PM Interaction with the cell adhesion molecule NEGR1 affects mGluR5 cell signalling November 4th / 7:30 AM Breakfast 2 Read More Saturday, November 4th / 8:15 AM Distinct sub-cellular signal Read More Saturday, November 4th / 8:40 AM Biochemical Mechanisms Underlying Location Bias in GPCR Signaling
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
These ligands stimulate receptor β-arrestin recruitment without activating canonical G protein signaling Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor signaling , they are exciting tools for linking distinct signaling pathways with their physiological effects and selectivity can be leveraged in the development of safe and effective treatments for stimulant and opioid
- Dr. Kathryn E Livingston | Dr. GPCR Ecosystem
John Traynor , Kathryn worked to develop and understand first-in-class allosteric modulators of opioid
- Session I | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Back to Full Agenda Session I Tethered agonist - dependent/independent activation mechanism in AGPCRs Signaling Region with Transmembrane Domain in a Holo-Adhesion GPCR Demet Araç Heterogeneity of Tethered Agonist Signaling It has been suggested that the TA can regulate receptor signaling without coming out of the GAIN domain The TA peptide remains at its original position and is not involved in signaling. As an undergraduate, he studied opioid receptor trafficking and G protein conformational dynamics in
- Revvity | Dr. GPCR Ecosystem
Whether you’re decoding signaling pathways or designing the next generation of therapeutics, Revvity it doesn't emit a strong signal when bound to the surface. TRF detection, which effectively filters out short-lived background signals. pathway, from ligand binding and G-protein activation to intracellular signaling readouts. All four formats are validated in well-established models like GLP1R and Mu opioid receptor (MOR), and
- Targeting adenosine signaling for immuno-oncology
Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Targeting adenosine signaling for immuno-oncology Date & Time Friday, November 3rd / 4:35 PM Abstract "Adenosine (ADO) signaling through Potent inhibitors of ADO signaling are currently being tested in cancer patients, including in randomized I will present our recent work on adenosine-producing ectonucleotidases and adenosine signaling and discuss
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
"I wasn't able to get stronger pain meds because of the opioid epidemic," he recalls. Serafini found himself repeatedly drawn to them, or more precisely, to RGS (Regulators of G protein Signaling him to BSL-3 labs to study persistent pain after SARS-CoV-2 infection, revealing novel immune-neuron signaling
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
The Practical Assessment of Signaling Bias Dr.
- Unveiling Non-Canonical Functions for Gαq Signaling Pathways
Committee Sponsors GPCR Retreat Program < Back to schedule Unveiling Non-Canonical Functions for Gαq Signaling During this period and her doctoral thesis, she has deepened the regulatory mechanisms of GPCR signaling characterization of proteins that act at the level of G proteins and which are part of a multimolecular signaling complex (AGS, de “Activators of G-protein signaling). Ribas has characterized the existence of a new signaling pathway with a relevant role in cardiac hypertrophy
- Biochemical Mechanisms Underlying Location Bias in GPCR Signaling
Sponsors GPCR Retreat Program < Back to schedule Biochemical Mechanisms Underlying Location Bias in GPCR Signaling His lab is also interested in identifying novel signal transduction mechanisms of GPCRs, such as the
- where signaling happens inside a cell | Dr. GPCR Ecosystem
Home → Flash News → where signaling happens inside a cell Why does it matter where signaling happens Published on November 13, 2025 Category Dr.GPCR Podcast Why does it matter where signaling happens inside This shift — from thinking about “pathways” to understanding localized signaling architecture — is what drove her to build a research career around spatial control of GPCR signaling. The way signals are organized defines specificity, drug response, and potential for targeted therapies
- Using food perception and bioamine signaling networks to slow aging
Contest Committee Sponsors GPCR Retreat Program < Back to schedule Using food perception and bioamine signaling laboratory focuses on how organisms perceive and respond to environmental stress though cell non autonomous signaling mechanisms, and how these signals affect the health and longevity of the animal."
- Distinct sub-cellular signal propagation as a component of functional selectivity
Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Distinct sub-cellular signal Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. He is a world-renowned expert in the field of cell signaling and GPCRs and made seminal contributions In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones
- Did you know that certain ergot derivatives can produce wash-resistant signalling through the 5-HT2B receptor persisting for many hours without losing potency or efficacy? By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that this phenomenon results from persistently/irreversibly internalised signalling receptor complexes. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! ➡️ https://www.ecosystem.drgpcr.com/receptor-activation-and-signaling/mechanisms-of-constitutive-and-agonist-induced-5-ht2b-internalization%2C-persistent-endosomal-signaling-and-paradoxical-regulation-of-agonist-pharmacology #gpcr#drgpcr | Dr. GPCR Ecosystem
Home → Flash News → Did you know that certain ergot derivatives can produce wash-resistant signalling By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that this phenomenon results from persistently/irreversibly internalised signalling receptor complexes. By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that this phenomenon results from persistently/irreversibly internalised signalling receptor complexes.
























